Constitutive Androstane Receptor 1 is Constitutively Bound to Chromatin and 'Primed' for Transactivation in Hepatocytes

• Published in: Molecular pharmacology 2019-01, Vol.95 (1), p.97-105
• Main Authors: McMahon, Michael, Ding, Shaohong, Jimenez, Lourdes Acosta, Terranova, Remi, Gerard, Marie-Apolline, Vitobello, Antonio, Moggs, Jonathan, Henderson, Colin J., Wolf, C. Roland
• Format: Article
• Language: English
• Subjects: Animals; Cell Nucleus - drug effects; Cell Nucleus - genetics; Cells, Cultured; Chromatin - genetics; Constitutive Androstane Receptor; ErbB Receptors - genetics; Erlotinib Hydrochloride - pharmacology; Female; Hepatocytes - drug effects; Hepatocytes - physiology; Humans; Mice; Mice, Inbred C57BL; Phenobarbital - pharmacology; Protein Isoforms - genetics; Receptors, Cytoplasmic and Nuclear - genetics; Transcriptional Activation - drug effects; Transcriptional Activation - genetics
• ISSN: 0026-895X; 1521-0111
• DOI: 10.1124/mol.118.113555

The constitutive androstane receptor (CAR) is a xenobiotic sensor expressed in hepatocytes that activates genes involved in drug metabolism, lipid homeostasis, and cell proliferation. Much progress has been made in understanding the mechanism of activation of human CAR by drugs and xenobiotics. However, many aspects of the activation pathway remain to be elucidated. In this report, we have used viral constructs to express human CAR, its splice variants, and mutant CAR forms in hepatocytes from Car−/− mice in vitro and in vivo. We demonstrate CAR expression rescued the ability of Car−/− hepatocytes to respond to a wide range of CAR activators including phenobarbital. Additionally, two major splice isoforms of human CAR, CAR2 and CAR3, were inactive with almost all the agents tested. In contrast to the current model of CAR activation, ectopic CAR1 is constitutively localized in the nucleus and is loaded onto Cyp2b10 gene in the absence of an inducing agent. In studies to elucidate the role of threonine T38 in CAR regulation, we found that the T38D mutant was inactive even in the presence of CAR activators. However, the T38A mutant was activated by CAR inducers, showing that T38 is not essential for CAR activation. Also, using the inhibitor erlotinib, we could not confirm a role for the epidermal growth factor receptor in CAR regulation. Our data suggest that CAR is constitutively bound to gene regulatory regions and is regulated by exogenous agents through a mechanism which involves protein phosphorylation in the nucleus.